Elbit Imaging announces termination of discussions for purchase of Gamida Cell
Elbit Imaging announced, following its announcement dated March 18, that Elbit Medical Technologies, a subsidiary of the company in which the company holds approximately 86% of the voting power, has announced that Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power, has notified Elbit Medical that the negotiations of a possible purchase of Gamida Cell by a global pharmaceutical company have been terminated. The company, Elbit Medical and Gamida Cell are evaluating the consequences of the above mentioned matter.
Terms and Privacy Policy